Recombinant Danio rerio Queuine tRNA-ribosyltransferase subunit qtrtd1 (qtrtd1)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, but this can be adjusted as needed.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing.
The tag type is determined during the production process. If you require a specific tag, please inform us for preferential development.
Synonyms
qtrt2; qtrtd1; Queuine tRNA-ribosyltransferase accessory subunit 2; Queuine tRNA-ribosyltransferase domain-containing protein 1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-416
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Danio rerio (Zebrafish) (Brachydanio rerio)
Target Names
qtrt2
Target Protein Sequence
MKLELSRVVQ GCRLGVLTGL GKSGQHSLEV PGCLLHTRCA TVPHLTQDTL LTLSDLPAVT QVSVDSLAEH HEVLEEFKEG VRKFAGLHDT VIFCSLHDSA SPSPAGHVTN KTVSVWGSGG RIELTAARFM SIQAAVQPDC YQSMADGETW QANTSRKRVR KAVDRTLAHL DECLVLHQKT QELKHAEIFG VVEGGDILEE RLRSARETAK RPVGGFVLDG FHSSAMDQDV RAQLIQETSA ELPQEKPRLV LGVGRPDEVI SCVEAGVDLF ESFFPFQVTE RGCALSFNYT IDPDPETAGT SASTVLECNG ETPEVKKPSA NEDVENMTPF EINLKDKRYR DDFRPLVEGC VCYCCQKHMR AYVHHLLVTN ELLAGVLLML HNMAHYLGFF KALRDAITSD RLQDFKNTVL HRRQGD
Uniprot No.

Target Background

Function
This protein is a non-catalytic subunit of queuine tRNA-ribosyltransferase (TGT). TGT catalyzes the base exchange of guanine (G) with queuine (Q) at position 34 (the anticodon wobble position) in tRNAs with GU(N) anticodons (tRNA-Asp, -Asn, -His, and -Tyr), resulting in the formation of the hypermodified nucleoside queuosine (7-(((4,5-cis-dihydroxy-2-cyclopenten-1-yl)amino)methyl)-7-deazaguanosine).
Database Links
Protein Families
Queuine tRNA-ribosyltransferase family, QTRT2 subfamily
Subcellular Location
Cytoplasm. Mitochondrion outer membrane; Peripheral membrane protein; Cytoplasmic side.

Q&A

What is the basic function of QTRTD1 in Danio rerio?

QTRTD1 (Queuine tRNA-ribosyltransferase domain-containing 1) in Danio rerio functions as a critical subunit of the queuine tRNA-ribosyltransferase enzyme complex. This complex catalyzes the exchange of queuine for guanine at the wobble position of tRNAs with GUN anticodons, forming the hypermodified nucleoside queuosine. The enzyme requires both QTRTD1 and QTRT1 (Queuine tRNA-ribosyltransferase catalytic subunit 1) to form an active heterodimeric complex . The functional quaternary structure is essential for proper tRNA modification activity, which plays a role in translational fidelity and efficiency.

What expression systems are most effective for producing recombinant Danio rerio QTRTD1?

Multiple expression systems have been successfully used for QTRTD1 production:

Expression SystemAdvantagesConsiderations
YeastGood for eukaryotic protein folding; moderate yieldLonger expression time; complex media requirements
BaculovirusHigh yield; proper post-translational modificationsMore complex setup; higher cost
E. coliRapid expression; cost-effective; high yieldMay require optimization for soluble expression

For optimal expression in E. coli, researchers should consider:

  • Using a tgt (-) E. coli strain containing rare codon tRNA expression plasmid [E. coli K12 (DE3, Δ tgt)-pRIPL] to eliminate residual transglycosylase activity from host cells and enhance heterologous expression

  • Supplementing growth media with Zn²⁺ (100 μM)

  • Employing low-temperature induction (19°C) to improve protein folding and solubility

What purification strategy yields the highest purity of recombinant QTRTD1?

A multi-step purification approach is recommended:

  • Initial capture: For His-tagged constructs, Ni²⁺ affinity chromatography provides effective initial purification

  • Intermediate purification: Size-exclusion chromatography to separate monomeric, heterodimeric, and homodimeric forms

  • Polishing: Ion exchange chromatography if higher purity is required

When co-expressing with QTRT1, it's noteworthy that QTRTD1 co-purifies with His-tagged QTRT1 via Ni²⁺ affinity chromatography, indicating their strong association in a heterodimeric complex . Purified proteins typically achieve >90% purity as determined by SDS-PAGE analysis .

How can researchers assess the enzymatic activity of recombinant QTRTD1?

The enzymatic activity of QTRTD1 should be assessed in complex with QTRT1, as neither subunit alone possesses full transglycosylase activity. A comprehensive activity assay includes:

  • Substrate preparation: Synthesize or isolate tRNA substrates containing GUN anticodons

  • Radiolabeled queuine incorporation assay: Measure the incorporation of radiolabeled queuine into tRNA substrates

  • HPLC analysis: Quantify the conversion of guanine to queuosine at the wobble position

  • Controls: Include appropriate negative controls such as QTRT1(D279N) mutant, which lacks catalytic activity but maintains structural integrity

It's important to note that the active enzyme is a heterodimer of QTRT1 and QTRTD1 in a 1:1 complex, and both components are required for full catalytic activity.

What methods can be used to study QTRTD1-QTRT1 complex formation?

Several complementary approaches can be employed:

  • Co-immunoprecipitation: Using antibodies against either protein to pull down the complex

  • Size-exclusion chromatography: Analyzing the elution profile to identify heterodimeric vs. homodimeric species

  • Mass spectrometry: Intact mass analysis has revealed that both QTRT1 and QTRTD1 can form homodimers, but the heterodimer is predominant

  • Analytical ultracentrifugation: Determining the sedimentation coefficient of the complex

  • Surface plasmon resonance: Measuring binding kinetics between the two proteins

Research has shown that intact mass analysis of purified complexes reveals peaks corresponding to both heterodimeric and homodimeric forms, with the heterodimer (QTRT1·QTRTD1) being the predominant species .

How does Danio rerio QTRTD1 compare structurally and functionally to its human ortholog?

Comparative analysis reveals significant conservation:

FeatureDanio rerio QTRTD1Human QTRTD1Significance
Protein Length416 amino acids 415 amino acids High conservation of domain architecture
Zn²⁺ Binding SitesConserved cysteine and histidine residues Cys302, Cys304, Cys307, His333 Functional conservation of catalytic sites
Heterodimer FormationForms complex with QTRT1 Forms complex with QTRT1 Conserved quaternary structure
Enzymatic ActivitytRNA-guanine transglycosylase activitytRNA-guanine transglycosylase activityConserved biochemical function

The high degree of conservation suggests that findings from zebrafish models may have translational relevance to human biology and disease models. Both proteins function as part of a heterodimeric enzyme complex with their respective QTRT1 partners to catalyze the same biochemical reaction.

What evolutionary insights can be gained from studying QTRTD1 across different species?

QTRTD1 represents an interesting evolutionary case study in enzyme complex formation. Unlike the homodimeric eubacterial TGT, eukaryotic tRNA-guanine transglycosylase exists as a heterodimer (QTRT1·QTRTD1) . This evolutionary divergence provides insights into:

  • Subfunctionalization: The splitting of ancestral functions between two paralogous proteins

  • Protein-protein interaction evolution: Development of specific interaction interfaces

  • Enzymatic specialization: Potential refinement of catalytic properties through heterodimer formation

The QTRT1 gene is conserved across diverse species including chimpanzee, canine, bovine, mouse, rat, zebrafish, fruit fly, mosquito, C. elegans, S. pombe, M. grisea, N. crassa, rice, and P. falciparum , suggesting an ancient origin and fundamental importance in tRNA modification.

How can QTRTD1 knockdown models be established in zebrafish?

Creating QTRTD1 knockdown or knockout models in zebrafish can be accomplished through several approaches:

  • Morpholino antisense oligonucleotides:

    • Design morpholinos targeting the translation start site or splice junctions

    • Inject into one-cell stage embryos (1-2 nl of 0.5-1 mM morpholino)

    • Include appropriate controls (mismatch morpholinos)

    • Validate knockdown efficiency by qRT-PCR and Western blotting

  • CRISPR/Cas9 genome editing:

    • Design sgRNAs targeting exonic regions of the qtrtd1 gene

    • Co-inject with Cas9 mRNA or protein

    • Screen F0 fish for mutations using T7 endonuclease assay or direct sequencing

    • Establish stable mutant lines through outcrossing and genotyping

  • shRNA-mediated knockdown:

    • Design vectors similar to the QTRT1 shRNA plasmid methodology

    • Optimize for zebrafish expression systems

    • Create transgenic lines with inducible expression systems

Each approach has advantages and limitations regarding specificity, efficiency, and temporal control of gene knockdown.

What role might QTRTD1 play in zebrafish optic nerve regeneration?

While direct evidence linking QTRTD1 to optic nerve regeneration is limited in the provided search results, several hypotheses can be formulated based on its function:

  • Translational control during regeneration: tRNA modifications affect translation efficiency and fidelity, which may be crucial during the reprogramming phase of regeneration where specific proteins need to be synthesized

  • Cell reprogramming mechanisms: The comprehensive gene regulatory reprogramming in zebrafish RGCs during axon regeneration may involve changes in translation regulation through tRNA modifications

  • Stress response pathways: tRNA modifications are known to be altered during cellular stress responses, which are activated during nerve injury

Research methodologies to investigate these hypotheses could include:

  • Temporal expression analysis of qtrtd1 during different phases of optic nerve regeneration

  • Localized knockdown of qtrtd1 in regenerating retinal ganglion cells

  • Profiling of tRNA modifications before and after optic nerve injury

  • Rescue experiments in qtrtd1-deficient models

How can researchers address low expression yields of recombinant QTRTD1?

Low expression yields of recombinant QTRTD1 can be addressed through systematic optimization:

  • Expression system selection:

    • If E. coli yields are poor, consider switching to yeast or baculovirus systems

    • For E. coli expression, use strains optimized for rare codon usage

  • Expression conditions optimization:

    • Supplement media with 100 μM Zn²⁺

    • Employ low-temperature induction (19°C)

    • Optimize IPTG concentration (typically 0.1-0.5 mM)

    • Extend expression time (overnight for low temperature)

  • Co-expression strategies:

    • Co-express with QTRT1 using dual protein expression vectors (e.g., pRSF-2 Ek/LIC)

    • Co-express with chaperones to improve folding

  • Construct optimization:

    • Try different affinity tags (His, GST, MBP)

    • Optimize codon usage for the expression host

    • Consider domain boundaries and flexible linkers

Each optimization parameter should be systematically tested and documented to determine optimal conditions for your specific experimental setup.

What are the common pitfalls in assessing QTRTD1-QTRT1 interaction, and how can they be addressed?

Several challenges may arise when studying QTRTD1-QTRT1 interactions:

  • Dynamic equilibrium issues:

    • Challenge: Mass spectrometry analysis has shown that both proteins can form homodimers along with the predominant heterodimer

    • Solution: Use chemical crosslinking to stabilize the preferred complex before analysis

  • Zinc dependency:

    • Challenge: Insufficient zinc leads to improper folding and unstable complexes

    • Solution: Ensure buffers contain appropriate Zn²⁺ concentrations (typically 10-100 μM)

  • Purification artifacts:

    • Challenge: The His-tag on one protein may artificially enhance apparent binding

    • Solution: Perform reciprocal tagging experiments and tag-free purification approaches

  • Inactive mutants:

    • Challenge: Distinguishing between structural and catalytic roles

    • Solution: Use well-characterized mutants like QTRT1(D279N) that maintain structure but lack activity

When designing interaction studies, researchers should carefully consider these factors to avoid misinterpretation of results and ensure robust, reproducible findings.

How might QTRTD1 function be relevant to human disease studies?

The fundamental role of QTRTD1 in tRNA modification suggests several potential connections to human disease mechanisms:

  • Translational dysregulation: Alterations in tRNA modifications can affect translational fidelity and efficiency, potentially contributing to diseases involving protein misfolding or aggregation

  • Cancer biology: Queuosine modification levels are altered in various cancer types, suggesting a potential role in tumorigenesis or tumor progression

  • Neurological disorders: Given the importance of precise translational control in neurons and the role of zebrafish QTRTD1 in contexts that include neural tissues , there may be connections to neurological disorders

Research approaches to investigate these connections could include:

  • CRISPR-based screens in zebrafish disease models

  • Correlation studies between QTRTD1 expression/activity and disease progression

  • Targeted modification of QTRTD1 in patient-derived cells

  • Development of small molecule modulators of QTRTD1-QTRT1 complex activity

What methodological approaches can be used to study the impact of QTRTD1 mutations on enzyme function?

To comprehensively assess the impact of QTRTD1 mutations:

  • Structure-based mutagenesis:

    • Target conserved residues (e.g., zinc-binding sites)

    • Create alanine scanning libraries across protein-protein interaction interfaces

    • Use site-directed mutagenesis to introduce specific mutations

  • Functional reconstitution assays:

    • Express wild-type and mutant proteins in a heterologous system

    • Purify and reconstitute the enzyme complex in vitro

    • Measure enzymatic activity using radiolabeled substrates or HPLC-based assays

  • Protein-protein interaction analysis:

    • Quantify binding affinity between mutant QTRTD1 and QTRT1 using SPR or ITC

    • Assess complex formation using size-exclusion chromatography

    • Visualize interaction using fluorescence resonance energy transfer (FRET)

  • In vivo validation:

    • Introduce equivalent mutations in zebrafish models using CRISPR/Cas9

    • Assess phenotypic consequences and perform rescue experiments

    • Measure queuosine modification levels in vivo

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.